| Formulation aspects of biodegradable polymeric microspheres for antigen delivery H Tamber, P Johansen, HP Merkle, B Gander Advanced drug delivery reviews 57 (3), 357-376, 2005 | 462 | 2005 |
| Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial G Senti, BM Prinz Vavricka, I Erdmann, MI Diaz, R Markus, SJ McCormack, ... Proceedings of the National Academy of Sciences 105 (46), 17908-17912, 2008 | 421 | 2008 |
| Immunity in response to particulate antigen-delivery systems T Storni, TM Kündig, G Senti, P Johansen Advanced drug delivery reviews 57 (3), 333-355, 2005 | 399 | 2005 |
| Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections G Senti, R Crameri, D Kuster, P Johansen, JM Martinez-Gomez, N Graf, ... Journal of Allergy and Clinical Immunology 129 (5), 1290-1296, 2012 | 310 | 2012 |
| Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination P Johansen, Y Men, HP Merkle, B Gander European Journal of Pharmaceutics and Biopharmaceutics 50 (1), 129-146, 2000 | 274 | 2000 |
| Use of A‐type CpG oligodeoxynucleotides as an adjuvant in allergen‐specific immunotherapy in humans: a phase I/IIa clinical trial G Senti, P Johansen, S Haug, C Bull, C Gottschaller, P Müller, T Pfister, ... Clinical & Experimental Allergy 39 (4), 562-570, 2009 | 266 | 2009 |
| Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy G Senti, N Graf, S Haug, N Rüedi, S von Moos, T Sonderegger, ... Journal of Allergy and Clinical Immunology 124 (5), 997-1002, 2009 | 262 | 2009 |
| Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression A Fettelschoss, M Kistowska, S LeibundGut-Landmann, HD Beer, ... Proceedings of the National Academy of Sciences 108 (44), 18055-18060, 2011 | 238 | 2011 |
| Administration routes affect the quality of immune responses: a cross-sectional evaluation of particulate antigen-delivery systems D Mohanan, B Slütter, M Henriksen-Lacey, W Jiskoot, JA Bouwstra, ... Journal of Controlled Release 147 (3), 342-349, 2010 | 235 | 2010 |
| Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives P Johansen, Y Men, R Audran, G Corradin, HP Merkle, B Gander Pharmaceutical research 15, 1103-1110, 1998 | 212 | 1998 |
| Antigen kinetics determines immune reactivity P Johansen, T Storni, L Rettig, Z Qiu, A Der-Sarkissian, KA Smith, ... Proceedings of the National Academy of Sciences 105 (13), 5189-5194, 2008 | 204 | 2008 |
| Epicutaneous allergen-specific immunotherapy ameliorates grass pollen–induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study G Senti, S von Moos, F Tay, N Graf, T Sonderegger, P Johansen, ... Journal of allergy and clinical immunology 129 (1), 128-135, 2012 | 182 | 2012 |
| Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology S Baenziger, M Heikenwalder, P Johansen, E Schlaepfer, U Hofer, ... Blood, The Journal of the American Society of Hematology 113 (2), 377-388, 2009 | 180 | 2009 |
| Intralymphatic injections as a new administration route for allergen-specific immunotherapy JM Martínez-Gómez, P Johansen, I Erdmann, G Senti, R Crameri, ... International archives of allergy and immunology 150 (1), 59-65, 2009 | 143 | 2009 |
| Direct intralymphatic injection of peptide vaccines enhances immunogenicity P Johansen, AC Häffner, F Koch, K Zepter, I Erdmann, K Maloy, JJ Simard, ... European journal of immunology 35 (2), 568-574, 2005 | 142 | 2005 |
| Technological considerations related to the up-scaling of protein microencapsulation by spray-drying P Johansen, HP Merkle, B Gander European Journal of Pharmaceutics and Biopharmaceutics 50 (3), 413-417, 2000 | 139 | 2000 |
| A virus-like particle-based vaccine selectively targeting soluble TNF-α protects from arthritis without inducing reactivation of latent tuberculosis G Spohn, R Guler, P Johansen, I Keller, M Jacobs, M Beck, F Rohner, ... The Journal of Immunology 178 (11), 7450-7457, 2007 | 129 | 2007 |
| Intralymphatic immunotherapy G Senti, P Johansen, TM Kündig Current opinion in allergy and clinical immunology 9 (6), 537-543, 2009 | 116 | 2009 |
| Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials G Senti, S von Moos, F Tay, N Graf, P Johansen, TM Kündig Allergy 70 (6), 707-710, 2015 | 101 | 2015 |
| Thermodynamic approach to protein microencapsulation into poly (D, L-lactide) by spray drying B Gander, P Johansen, H Nam-Trân, HP Merkle International Journal of Pharmaceutics 129 (1-2), 51-61, 1996 | 100 | 1996 |
